Developing e-Covery, an App-based Intervention to Support Individuals With Co-occurring Problem Alcohol and Opioid Use
NCT ID: NCT05325788
Last Updated: 2024-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2022-11-04
2023-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Digital Mindfulness-Based Treatment for Substance Use Disorder Recovery
NCT05852015
Co-Use of Opioid Medications and Alcohol Prevention Study
NCT05599672
Computerized Alcohol Misuse Intervention System for Health Care
NCT02368899
Integrating Combined Therapies for Persons With Co-occurring Disorders
NCT02598518
An Integrated Substance Abuse-Domestic Violence (SADV) Treatment Outcome Study
NCT07140276
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This project aims to improve the health of individuals engaged in co-occurring alcohol and opioid use by supporting the maintenance of behavior change initiated in substance use treatment. Building on prior research, this study will entail a stage 1b pilot to test the feasibility and acceptability of an app-based intervention for individuals reporting co-occurring alcohol and opioid use. The intervention will involve modifying an app currently used in a research study to collect GPS information to send push notifications when individuals encounter self-identified place-based triggers. Thirty individuals completing substance use treatment will consent to use the app for a thirty-day pilot period and will complete assessments of intervention feasibility and acceptability. Using within-subject tests, the analysis will summarize participant responses to assessments and will compare the use of general messaging to place-specific messaging.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single daily message followed by location-based messaging
Participants in this condition receive a single daily message through the intervention app for two weeks (14 days) followed by location-based messaging for two weeks (14 days).
e-Covery
Through the e-Covery app, participants will receive place-specific messages, sent when participants pass locations identified as triggers.
Comparator Condition
Through the e-Covery app, participants will receive a single general message sent daily in the morning.
Location-based messaging followed by single daily message
Participants in this condition receive location-based messaging through the intervention app for two weeks (14 days) followed by a single daily message for two weeks (14 days) .
e-Covery
Through the e-Covery app, participants will receive place-specific messages, sent when participants pass locations identified as triggers.
Comparator Condition
Through the e-Covery app, participants will receive a single general message sent daily in the morning.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
e-Covery
Through the e-Covery app, participants will receive place-specific messages, sent when participants pass locations identified as triggers.
Comparator Condition
Through the e-Covery app, participants will receive a single general message sent daily in the morning.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* report enrollment in a substance use treatment program at baseline
* report use above the screening tool thresholds for problem alcohol use
* own a smartphone
* reside in Connecticut at baseline with no plans to move in the following month
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Viera
Role: PRINCIPAL_INVESTIGATOR
Yale University School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ENRICH Lab
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000031915
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.